Upgrade to SI Premium - Free Trial

Molina Healthcare Reports Second Quarter 2019 Financial Results

July 30, 2019 4:15 PM

Raises Full Year 2019 Earnings Guidance

LONG BEACH, Calif.--(BUSINESS WIRE)-- Molina Healthcare, Inc. (NYSE: MOH) today reported net income for the second quarter of 2019 of $196 million, or $3.06 per diluted share compared to net income of $202 million, or $3.02 per diluted share, in the second quarter of 2018. Financial results for the second quarter of 2019, are summarized below:

Three Months Ended

Six Months Ended

June 30,

June 30,

2019

2018

2019

2018

(In millions, except per share results)

Premium Revenue

$4,049

$4,514

$8,001

$8,837

Total Revenue

$4,193

$4,883

$8,312

$9,529

Pre-Tax Income

$257

$305

$517

$484

Net Income

$196

$202

$394

$309

EPS - Diluted

$3.06

$3.02

$6.04

$4.68

MCR

85.6

%

85.3

%

85.5

%

85.7

%

G&A Ratio

7.8

%

6.9

%

7.6

%

7.2

%

Pre-Tax Margin

6.1

%

6.2

%

6.2

%

5.1

%

Effective Tax Rate

24.0

%

33.8

%

23.9

%

36.2

%

After-Tax Margin

4.7

%

4.1

%

4.7

%

3.2

%

Highlights include:

“We are very pleased with our strong start to the year, a year in which we intend to demonstrate that we can sustain our attractive margin profile while pivoting to growth,” said Joe Zubretsky, president and CEO. “The business continues to generate significant excess cash flow and our revenue growth initiatives are well under way. Our quarter and year to date results, and the earnings trajectory of our entire portfolio of businesses leading into the second half of the year, give us the confidence to raise full year guidance.”

Premium Revenue

Premium revenue for the second quarter of 2019 decreased 10.3% to $4.0 billion compared to $4.5 billion in the second quarter of 2018, which was in line with Company expectations.

For the six months ended June 30, 2019, premium revenue decreased 9.5% to $8.0 billion from $8.8 billion for the comparable period in 2018. In both periods, the lower premium revenue is primarily a result of lower Medicaid membership due to the previously announced loss of the New Mexico Medicaid contract, along with the resizing of the Florida Medicaid contract and the related transition out of all but two Florida regions as reported throughout 2018.

Medical Care Ratio

The consolidated MCR for the second quarter of 2019 was 85.6% compared to 85.3% in the second quarter of 2018. Favorable prior period development for the second quarter was $28 million pre-tax.

The MCR for the six months ended June 30, 2019, improved to 85.5% compared to 85.7% for the comparable period in 2018, due to a combination of the following:

General and Administrative Expense Ratio

The general and administrative expenses were 7.8% of total revenues in the second quarter of 2019 compared to 6.9% in the second quarter of 2018.

For the six months ended June 30, 2019, the G&A ratio was 7.6% compared to 7.2% in the comparable prior-year period. In both periods, the year-over-year increases are mainly associated with the decrease in premium revenue.

Interest Expense

The second quarter interest expense was $22 million compared to $32 million in the second quarter of 2018. The decline was due to continued repayment of debt.

Restructuring Costs/Other Income and Expenses

The second quarter results benefited from a $14 million gain on the repayment of convertible notes in the current period, offset somewhat by $2 million in restructuring costs, resulting in a $0.15 net benefit per diluted share.

Balance Sheet

Cash at the parent company amounted to $467 million as of June 30, 2019, compared to $443 million as of March 31, 2019.

During the quarter the Company received $345 million of dividends from the regulated health plan subsidiaries.

The Company made $139 million in principal repayments on the convertible notes during the quarter and $185 million in repayments since the beginning of the year. The impact of capital deployment actions in the quarter resulted in lower interest expense, a gain on repayment of the convertible notes and a lower share count.

Cash Flow

Operating cash flows for the six months ended June 30, 2019, was $156 million and is lower compared to the six months ended June 30, 2018, primarily due to timing of government payments.

Outlook

The Company raised its full year 2019 earnings guidance range to $11.20 to $11.50 per diluted share, with a midpoint of $11.35, from previously issued guidance of $10.50 to $11.00.

Guidance is based on the following:

July 30, 2019 (1)

April 29, 2019 (1)

(current)

(previous)

Premium revenue

$16.1B

$15.9B

Medicaid

$12.3B

$12.2B

Medicare

$2.2B

$2.2B

Marketplace

$1.6B

$1.5B

Premium tax revenue

$450M

$425M

Investment income and other revenue

$115M

$115M

Total revenue

$16.7B

$16.4B

Medical care costs

$13.8B

$13.6B

General and administrative expenses

$1.3B

$1.3B

Premium tax expenses

$450M

$425M

EBITDA (2)

$1,135M - $1,160M

$1,080M - $1,120M

Depreciation and amortization

$90M

$90M

Interest expense and other expenses, net

$90M

$90M

Income before income taxes

$955M - $980M

$900M - $940M

Net income

$725M - $740M

$680M - $710M

Net income per share

$11.20 - $11.50

$10.50 - $11.00

Diluted weighted average shares

64.5M

64.7M

End-of-year membership:

Medicaid and Medicare

3.1M

3.1M

Marketplace

270K - 280K

270K - 280K

Operating Statistics:

Medical care ratio

86%

86%

G&A ratio

7.7%

7.7%

Effective income tax expense rate

24.2%

24.5%

After-tax margin

4.2% - 4.4%

4.1% - 4.3%

Medicaid

3%

3%

Medicare

7%

6%

Marketplace

11%

11%

__________________

(1)

All amounts are rounded and approximations.

(2)

See reconciliation of non-GAAP financial measures at the end of this release.

Conference Call

Management will host a conference call and webcast to discuss Molina Healthcare’s second quarter 2019 results at 8:00 a.m. Eastern time on Wednesday, July 31, 2019. The number to call for the interactive teleconference is (877) 883-0383 and the confirmation number is 0428160. A telephonic replay of the conference call will be available through Wednesday, August 7, 2019, by dialing (877) 344-7529 and entering confirmation number 10132714. A live audio broadcast of this conference call will be available on Molina Healthcare’s website, molinahealthcare.com. A 30-day online replay will be available approximately an hour following the conclusion of the live broadcast.

About Molina Healthcare

Molina Healthcare, Inc., a FORTUNE 500 company, provides managed health care services under the Medicaid and Medicare programs and through the state insurance marketplaces. Through its locally operated health plans, Molina Healthcare served approximately 3.4 million members as of June 30, 2019. For more information about Molina Healthcare, please visit molinahealthcare.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This earnings release contains forward-looking statements regarding the Company’s revised 2019 guidance, as well as its plans, expectations, and anticipated future events. Actual results could differ materially due to numerous known and unknown risks and uncertainties. Those risks and uncertainties are discussed in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, and the section entitled “Forward-Looking Statements” in the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2019.

These reports can be accessed under the investor relations tab of the Company’s website or on the SEC’s website at sec.gov. Given these risks and uncertainties, the Company can give no assurances that its forward-looking statements will prove to be accurate, or that any other results or events projected or contemplated by its forward-looking statements will in fact occur, and the Company cautions investors not to place undue reliance on these statements. All forward-looking statements in this release represent the Company’s judgment as of July 30, 2019, and, except as otherwise required by law, the Company disclaims any obligation to update any forward-looking statements to conform the statement to actual results or changes in its expectations.

UNAUDITED CONSOLIDATED STATEMENTS OF INCOME

Three Months Ended

Six Months Ended

June 30,

June 30,

2019

2018

2019

2018

(In millions, except per-share amounts)

Revenue:

Premium revenue

$

4,049

$

4,514

$

8,001

$

8,837

Premium tax revenue

110

106

248

210

Health insurer fees reimbursed

104

165

Service revenue

127

261

Investment income and other revenue

34

32

63

56

Total revenue

4,193

4,883

8,312

9,529

Operating expenses:

Medical care costs

3,466

3,850

6,837

7,572

General and administrative expenses

328

335

630

687

Premium tax expenses

110

106

248

210

Health insurer fees

99

174

Depreciation and amortization

22

25

47

51

Restructuring costs

2

8

5

33

Cost of service revenue

118

238

Total operating expenses

3,928

4,541

7,767

8,965

Operating income

265

342

545

564

Other expenses, net:

Interest expense

22

32

45

65

Other (income) expenses, net

(14

)

5

(17

)

15

Total other expenses, net

8

37

28

80

Income before income tax expense

257

305

517

484

Income tax expense

61

103

123

175

Net income

$

196

$

202

$

394

$

309

Net income per share, diluted

$

3.06

$

3.02

$

6.04

$

4.68

Diluted weighted average shares outstanding

64.0

66.7

65.1

66.0

Operating Statistics:

Medical care ratio

85.6

%

85.3

%

85.5

%

85.7

%

G&A ratio

7.8

%

6.9

%

7.6

%

7.2

%

Premium tax ratio

2.6

%

2.3

%

3.0

%

2.3

%

Effective income tax expense rate

24.0

%

33.8

%

23.9

%

36.2

%

After-tax margin

4.7

%

4.1

%

4.7

%

3.2

%

Medicaid

3.1

%

2.3

%

3.0

%

1.6

%

Medicare

7.1

%

5.7

%

7.4

%

4.9

%

Marketplace

11.2

%

16.9

%

13.6

%

17.4

%

CONSOLIDATED BALANCE SHEETS

June 30,

Dec. 31,

2019

2018

Unaudited

(Dollars in millions,
except per-share
amounts)

ASSETS

Current assets:

Cash and cash equivalents

$

2,253

$

2,826

Investments

2,070

1,681

Receivables

1,239

1,330

Prepaid expenses and other current assets

132

149

Derivative asset

169

476

Total current assets

5,863

6,462

Property, equipment, and capitalized software, net

373

241

Goodwill and intangible assets, net

180

190

Restricted investments

98

120

Deferred income taxes

70

117

Other assets

106

24

$

6,690

$

7,154

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Medical claims and benefits payable

$

1,767

$

1,961

Amounts due government agencies

984

967

Accounts payable and accrued liabilities

373

390

Deferred revenue

30

211

Current portion of long-term debt

65

241

Derivative liability

169

476

Total current liabilities

3,388

4,246

Long-term debt

1,241

1,020

Finance lease liabilities

232

197

Other long-term liabilities

93

44

Total liabilities

4,954

5,507

Stockholders’ equity:

Common stock, $0.001 par value, 150 million shares authorized; outstanding: 63 million shares at June 30, 2019 and 62 million shares at December 31, 2018

Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding

Additional paid-in capital

240

643

Accumulated other comprehensive income (loss)

5

(8

)

Retained earnings

1,491

1,012

Total stockholders’ equity

1,736

1,647

$

6,690

$

7,154

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Three Months Ended

Six Months Ended

June 30,

June 30,

2019

2018

2019

2018

(In millions)

Operating activities:

Net income

$

196

$

202

$

394

$

309

Adjustments to reconcile net income to net cash (used in) provided by operating activities:

Depreciation and amortization

22

36

47

73

Deferred income taxes

4

19

(6

)

Share-based compensation

10

7

19

13

Amortization of convertible senior notes and finance lease liabilities

1

6

4

13

(Gain) loss on debt extinguishment

(14

)

5

(17

)

15

Non-cash restructuring costs

17

Other, net

2

3

4

Changes in operating assets and liabilities:

Receivables

120

(232

)

91

(315

)

Prepaid expenses and other current assets

(2

)

58

18

(181

)

Medical claims and benefits payable

(228

)

(104

)

(194

)

(267

)

Amounts due government agencies

52

33

17

205

Accounts payable and accrued liabilities

(31

)

30

(61

)

349

Deferred revenue

(177

)

(172

)

(181

)

(42

)

Income taxes

(46

)

49

(3

)

127

Net cash (used in) provided by operating activities

(93

)

(80

)

156

314

Investing activities:

Purchases of investments

(977

)

(525

)

(1,162

)

(914

)

Proceeds from sales and maturities of investments

425

792

791

1,335

Purchases of property, equipment, and capitalized software

(14

)

(10

)

(20

)

(14

)

Other, net

2

(4

)

(2

)

(9

)

Net cash (used in) provided by investing activities

(564

)

253

(393

)

398

Financing activities:

Repayment of principal amount of 1.125% Convertible Notes

(139

)

(89

)

(185

)

(89

)

Cash paid for partial settlement of 1.125% Conversion Option

(358

)

(134

)

(473

)

(134

)

Cash received for partial termination of 1.125% Call Option

358

134

473

134

Cash paid for partial termination of 1.125% Warrants

(321

)

(113

)

(424

)

(113

)

Proceeds from borrowings under Term Loan Facility

120

220

Repayment of Credit Facility

(300

)

(300

)

Other, net

26

4

27

(1

)

Net cash used in financing activities

(314

)

(498

)

(362

)

(503

)

Net (decrease) increase in cash, cash equivalents, and restricted cash and cash equivalents

(971

)

(325

)

(599

)

209

Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period

3,298

3,824

2,926

3,290

Cash, cash equivalents, and restricted cash and cash equivalents at end of period

$

2,327

$

3,499

$

2,327

$

3,499

HEALTH PLANS SEGMENT MEMBERSHIP

June 30,
2019

Dec. 31,
2018

June 30,
2018

Ending Membership by Government Program:

TANF and CHIP

2,008,000

2,295,000

2,464,000

Medicaid Expansion

595,000

660,000

675,000

ABD

359,000

406,000

415,000

Total Medicaid

2,962,000

3,361,000

3,554,000

MMP - Integrated

57,000

54,000

55,000

Medicare Special Needs Plans

43,000

44,000

45,000

Total Medicare

100,000

98,000

100,000

Total Medicaid and Medicare

3,062,000

3,459,000

3,654,000

Marketplace

308,000

362,000

409,000

3,370,000

3,821,000

4,063,000

Ending Membership by Health Plan:

California

590,000

608,000

639,000

Florida (1)

142,000

313,000

398,000

Illinois

221,000

224,000

219,000

Michigan

360,000

383,000

397,000

New Mexico (1)

26,000

222,000

241,000

Ohio

297,000

302,000

320,000

Puerto Rico

200,000

252,000

326,000

South Carolina

130,000

120,000

114,000

Texas

360,000

423,000

450,000

Washington

811,000

781,000

776,000

Other (2)

233,000

193,000

183,000

3,370,000

3,821,000

4,063,000

__________________

(1)

The Company’s Medicaid contracts in New Mexico and in all but two regions in Florida terminated in late 2018 and early 2019. During 2019, the Company continues to serve Medicare and Marketplace members in both Florida and New Mexico, as well as Medicaid members in two regions in Florida.

(2)

“Other” includes the Idaho, Mississippi, New York, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results.

UNAUDITED SELECTED FINANCIAL DATA

(In millions, except percentages and per-member per-month amounts)

HEALTH PLANS SEGMENT FINANCIAL DATA — BY GOVERNMENT PROGRAM

Member

Months (1)

Premium Revenue

Medical Care Costs

MCR (2)

Medical
Margin

Total

PMPM

Total

PMPM

Three Months Ended June 30, 2019

TANF and CHIP

6.1

$

1,196

$

196.36

$

1,048

$

172.13

87.7

%

$

148

Medicaid Expansion

1.8

695

384.94

594

328.85

85.4

101

ABD

1.1

1,176

1,088.48

1,061

981.84

90.2

115

Total Medicaid

9.0

3,067

341.72

2,703

301.15

88.1

364

MMP

0.1

406

2,421.89

356

2,118.95

87.5

50

Medicare

0.2

166

1,296.99

132

1,034.43

79.8

34

Total Medicare

0.3

572

1,934.17

488

1,648.73

85.2

84

Total Medicaid and Medicare

9.3

3,639

392.52

3,191

344.14

87.7

448

Marketplace

0.9

410

440.20

275

295.71

67.2

135

10.2

$

4,049

$

396.87

$

3,466

$

339.72

85.6

%

$

583

Three Months Ended June 30, 2018

TANF and CHIP

7.5

$

1,393

$

186.18

$

1,205

$

161.13

86.5

%

$

188

Medicaid Expansion

2.1

761

372.04

676

330.83

88.9

85

ABD

1.3

1,288

1,033.34

1,209

969.27

93.8

79

Total Medicaid

10.9

3,442

319.52

3,090

286.89

89.8

352

MMP

0.1

367

2,224.30

313

1,893.91

85.1

54

Medicare

0.2

157

1,168.40

133

989.33

84.7

24

Total Medicare

0.3

524

1,751.49

446

1,488.85

85.0

78

Total Medicaid and Medicare

11.2

3,966

358.23

3,536

319.37

89.2

430

Marketplace

1.2

548

440.93

314

253.04

57.4

234

12.4

$

4,514

$

366.57

$

3,850

$

312.68

85.3

%

$

664

Six Months Ended June 30, 2019

TANF and CHIP

12.3

$

2,369

$

192.83

$

2,070

$

168.56

87.4

%

$

299

Medicaid Expansion

3.6

1,359

377.30

1,188

329.65

87.4

171

ABD

2.2

2,343

1,078.40

2,103

967.59

89.7

240

Total Medicaid

18.1

6,071

336.20

5,361

296.85

88.3

710

MMP

0.3

794

2,388.88

689

2,073.30

86.8

105

Medicare

0.3

329

1,290.88

265

1,041.06

80.6

64

Total Medicare

0.6

1,123

1,911.98

954

1,624.97

85.0

169

Total Medicaid and Medicare

18.7

7,194

385.82

6,315

338.67

87.8

879

Marketplace

1.9

807

415.94

522

269.14

64.7

285

20.6

$

8,001

$

388.66

$

6,837

$

332.11

85.5

%

$

1,164

Six Months Ended June 30, 2018

TANF and CHIP

14.9

$

2,766

$

185.66

$

2,477

$

166.32

89.6

%

$

289

Medicaid Expansion

4.1

1,513

372.39

1,317

324.19

87.1

196

ABD

2.5

2,542

1,023.83

2,364

951.99

93.0

178

Total Medicaid

21.5

6,821

318.11

6,158

287.22

90.3

663

MMP

0.3

724

2,180.86

618

1,858.87

85.2

106

Medicare

0.3

314

1,178.58

264

992.05

84.2

50

Total Medicare

0.6

1,038

1,735.05

882

1,473.30

84.9

156

Total Medicaid and Medicare

22.1

7,859

356.59

7,040

319.43

89.6

819

Marketplace

2.6

978

373.67

532

203.34

54.4

446

24.7

$

8,837

$

358.40

$

7,572

$

307.11

85.7

%

$

1,265

__________________

(1) A member month is defined as the aggregate of each month’s ending membership for the period presented.

(2) The MCR represents medical costs as a percentage of premium revenue.

HEALTH PLANS SEGMENT FINANCIAL DATA — MEDICAID AND MEDICARE

Member

Months

Premium Revenue

Medical Care Costs

MCR

Medical
Margin

Total

PMPM

Total

PMPM

Three Months Ended June 30, 2019

California

1.6

$

499

$

305.40

$

415

$

253.85

83.1

%

$

84

Florida

0.3

126

417.10

120

399.22

95.7

6

Illinois

0.6

242

364.15

215

323.96

89.0

27

Michigan

1.1

403

376.39

332

310.08

82.4

71

Ohio

0.9

630

701.22

553

615.59

87.8

77

Puerto Rico

0.6

122

198.95

109

177.56

89.2

13

South Carolina

0.4

140

362.24

125

322.55

89.0

15

Texas

0.7

598

916.74

551

844.02

92.1

47

Washington

2.4

611

257.79

535

225.67

87.5

76

Other (1) (2)

0.7

268

394.85

236

347.43

88.0

32

9.3

$

3,639

$

392.52

$

3,191

$

344.14

87.7

%

$

448

Three Months Ended June 30, 2018

California

1.8

$

517

$

289.80

$

441

$

247.36

85.4

%

$

76

Florida

1.2

377

353.81

362

339.31

95.9

15

Illinois

0.6

203

311.60

170

261.59

84.0

33

Michigan

1.2

388

342.45

331

292.20

85.3

57

New Mexico (2)

0.7

313

469.88

290

435.36

92.7

23

Ohio

1.0

535

571.08

482

514.57

90.1

53

Puerto Rico

0.9

184

188.26

165

168.20

89.3

19

South Carolina

0.4

123

350.22

107

304.20

86.9

16

Texas

0.7

576

835.66

510

740.55

88.6

66

Washington

2.2

571

252.61

526

232.49

92.0

45

Other (1)

0.5

179

322.99

152

274.59

85.0

27

11.2

$

3,966

$

358.23

$

3,536

$

319.37

89.2

%

$

430

Six Months Ended June 30, 2019

California

3.3

$

998

$

302.59

$

863

$

261.66

86.5

%

$

135

Florida

0.7

288

399.86

247

343.24

85.8

41

Illinois

1.3

469

356.16

400

303.50

85.2

69

Michigan

2.2

798

369.66

658

305.00

82.5

140

Ohio

1.8

1,220

680.20

1,090

607.85

89.4

130

Puerto Rico

1.2

224

181.91

199

161.40

88.7

25

South Carolina

0.8

276

362.68

240

315.84

87.1

36

Texas

1.3

1,197

909.59

1,083

822.59

90.4

114

Washington

4.8

1,225

258.10

1,121

236.19

91.5

104

Other (1) (2)

1.3

499

383.07

414

317.56

82.9

85

18.7

$

7,194

$

385.82

$

6,315

$

338.67

87.8

%

$

879

Six Months Ended June 30, 2018

California

3.6

$

1,011

$

281.14

$

853

$

237.26

84.4

%

$

158

Florida

2.2

759

352.68

707

328.26

93.1

52

Illinois

1.1

344

305.94

292

259.87

84.9

52

Michigan

2.3

764

339.56

662

294.19

86.6

102

New Mexico

1.4

632

468.00

600

444.44

95.0

32

Ohio

1.9

1,086

573.87

942

497.75

86.7

144

Puerto Rico

1.9

370

190.68

339

174.74

91.6

31

South Carolina

0.7

245

349.15

211

300.87

86.2

34

Texas

1.4

1,138

822.72

1,029

744.05

90.4

109

Washington

4.5

1,155

254.64

1,100

242.48

95.2

55

Other (1)

1.1

355

318.94

305

273.97

85.9

50

22.1

$

7,859

$

356.59

$

7,040

$

319.43

89.6

%

$

819

__________________

(1) “Other” includes the Idaho, Mississippi, New York, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results.

(2) In 2019, “Other” includes the New Mexico health plan. The New Mexico health plan’s Medicaid contract terminated on December 31, 2018, and therefore its 2019 results are not individually significant to the Company’s consolidated operating results.

HEALTH PLANS SEGMENT FINANCIAL DATA — MARKETPLACE

Member
Months

Premium Revenue

Medical Care Costs

MCR

Medical
Margin

Total

PMPM

Total

PMPM

Three Months Ended June 30, 2019

California

0.2

$

61

$

382.22

$

35

$

220.31

57.6

%

$

26

Florida

0.1

50

390.03

30

236.50

60.6

20

Michigan

10

521.67

6

308.37

59.1

4

Ohio

0.1

24

754.67

19

565.69

75.0

5

Texas

0.3

167

379.29

117

267.12

70.4

50

Washington

0.1

51

803.11

35

548.48

68.3

16

Other (1)

0.1

47

527.41

33

376.04

71.3

14

0.9

$

410

$

440.20

$

275

$

295.71

67.2

%

$

135

Three Months Ended June 30, 2018

California

0.2

$

73

$

426.16

$

21

$

117.92

27.7

%

$

52

Florida

0.1

100

698.31

38

269.86

38.6

62

Michigan

15

288.67

7

146.97

50.9

8

New Mexico

31

418.82

18

247.06

59.0

13

Ohio

31

518.64

23

381.46

73.6

8

Texas

0.7

222

330.12

160

238.72

72.3

62

Washington

0.2

56

787.80

41

572.48

72.7

15

Other (2)

20

NM

6

NM

NM

14

1.2

$

548

$

440.93

$

314

$

253.04

57.4

%

$

234

Six Months Ended June 30, 2019

California

0.3

$

117

$

361.73

$

68

$

210.71

58.2

%

$

49

Florida

0.3

111

406.52

56

205.17

50.5

55

Michigan

20

492.23

11

255.98

52.0

9

Ohio

0.1

54

805.96

34

505.10

62.7

20

Texas

0.9

315

341.18

226

245.82

72.0

89

Washington

0.1

98

756.26

64

490.84

64.9

34

Other (1)

0.2

92

501.13

63

344.61

68.8

29

1.9

$

807

$

415.94

$

522

$

269.14

64.7

%

$

285

Six Months Ended June 30, 2018

California

0.4

$

122

$

334.47

$

52

$

141.73

42.4

%

$

70

Florida

0.3

145

468.36

22

73.13

15.6

123

Michigan

0.1

28

254.69

16

145.49

57.1

12

New Mexico

0.1

65

429.19

37

246.77

57.5

28

Ohio

0.1

57

458.48

40

319.53

69.7

17

Texas

1.4

451

318.93

306

216.83

68.0

145

Washington

0.2

95

653.89

71

486.90

74.5

24

Other (2)

15

NM

(12

)

NM

NM

27

2.6

$

978

$

373.67

$

532

$

203.34

54.4

%

$

446

__________________

(1)

“Other” includes the New Mexico, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results in 2019.

(2)

“Other” includes the Utah and Wisconsin health plans, where the Company did not participate in the Marketplace in 2018. Therefore, the ratios for 2018 periods are not meaningful (NM).

HEALTH PLANS SEGMENT FINANCIAL DATA — TOTAL

Member

Months

Premium Revenue

Medical Care Costs

MCR

Medical Margin

Total

PMPM

Total

PMPM

Three Months Ended June 30, 2019

California

1.8

$

560

$

312.21

$

450

$

250.87

80.4

%

$

110

Florida

0.4

176

408.99

150

350.47

85.7

26

Illinois

0.6

242

364.15

215

323.96

89.0

27

Michigan

1.1

413

378.86

338

310.05

81.8

75

Ohio

1.0

654

703.09

572

613.85

87.3

82

Puerto Rico

0.6

122

198.95

109

177.56

89.2

13

South Carolina

0.4

140

362.24

125

322.55

89.0

15

Texas

1.0

765

700.15

668

611.53

87.3

97

Washington

2.5

662

271.96

570

234.05

86.1

92

Other (1) (2)

0.8

315

410.27

269

350.76

85.5

46

10.2

$

4,049

$

396.87

$

3,466

$

339.72

85.6

%

$

583

Three Months Ended June 30, 2018

California

2.0

$

590

$

301.73

$

462

$

236.04

78.2

%

$

128

Florida

1.3

477

394.38

400

331.13

84.0

77

Illinois

0.6

203

311.60

170

261.59

84.0

33

Michigan

1.2

403

340.08

338

285.78

84.0

65

New Mexico (2)

0.7

344

464.90

308

416.99

89.7

36

Ohio

1.0

566

567.96

505

506.66

89.2

61

Puerto Rico

0.9

184

188.26

165

168.20

89.3

19

South Carolina

0.4

123

350.22

107

304.20

86.9

16

Texas

1.4

798

585.50

670

492.23

84.1

128

Washington

2.4

627

268.84

567

242.80

90.3

60

Other (1)

0.5

199

360.90

158

285.65

79.1

41

12.4

$

4,514

$

366.57

$

3,850

$

312.68

85.3

%

$

664

Six Months Ended June 30, 2019

California

3.6

$

1,115

$

307.88

$

931

$

257.10

83.5

%

$

184

Florida

1.0

399

401.69

303

305.23

76.0

96

Illinois

1.3

469

356.16

400

303.50

85.2

69

Michigan

2.2

818

371.91

669

304.10

81.8

149

Ohio

1.9

1,274

684.77

1,124

604.12

88.2

150

Puerto Rico

1.2

224

181.91

199

161.40

88.7

25

South Carolina

0.8

276

362.68

240

315.84

87.1

36

Texas

2.2

1,512

675.34

1,309

584.90

86.6

203

Washington

4.9

1,323

271.34

1,185

242.96

89.5

138

Other

1.5

591

397.61

477

320.90

80.7

114

20.6

$

8,001

$

388.66

$

6,837

$

332.11

85.5

%

$

1,164

Six Months Ended June 30, 2018

California

4.0

$

1,133

$

286.07

$

905

$

228.44

79.9

%

$

228

Florida

2.5

904

367.18

729

296.29

80.7

175

Illinois

1.1

344

305.94

292

259.87

84.9

52

Michigan

2.4

792

335.59

678

287.23

85.6

114

New Mexico

1.5

697

464.11

637

424.58

91.5

60

Ohio

2.0

1,143

566.77

982

486.79

85.9

161

Puerto Rico

1.9

370

190.68

339

174.74

91.6

31

South Carolina

0.7

245

349.15

211

300.87

86.2

34

Texas

2.8

1,589

567.95

1,335

477.43

84.1

254

Washington

4.7

1,250

267.01

1,171

250.05

93.6

79

Other

1.1

370

333.35

293

263.24

79.0

77

24.7

$

8,837

$

358.40

$

7,572

$

307.11

85.7

%

$

1,265

__________________

(1)

“Other” includes the Idaho, Mississippi, New York, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results.

(2)

In 2019, “Other” includes the New Mexico health plan. The New Mexico health plan’s Medicaid contract terminated on December 31, 2018, and therefore its 2019 results are not individually significant to the Company’s consolidated operating results.

SELECTED FINANCIAL DATA

The following table provides details of the Company’s medical care costs for the periods indicated:

Three Months Ended June 30,

2019

2018

Amount

PMPM

% of
Total

Amount

PMPM

% of
Total

Fee for service

$

2,594

$

254.36

74.8

%

$

2,861

$

232.40

74.4

%

Pharmacy

429

42.06

12.4

567

46.05

14.7

Capitation

288

28.17

8.3

282

22.89

7.3

Other

155

15.13

4.5

140

11.34

3.6

$

3,466

$

339.72

100.0

%

$

3,850

$

312.68

100.0

%

Six Months Ended June 30,

2019

2018

Amount

PMPM

% of

Total

Amount

PMPM

% of

Total

Fee for service

$

5,108

$

248.18

74.7

%

$

5,606

$

227.38

74.1

%

Pharmacy

842

40.88

12.3

1,150

46.66

15.2

Capitation

573

27.81

8.4

594

24.09

7.8

Other

314

15.24

4.6

222

8.98

2.9

$

6,837

$

332.11

100.0

%

$

7,572

$

307.11

100.0

%

The following table provides details of the Company’s medical claims and benefits payable as of the dates indicated:

June 30,

Dec. 31,

2019

2018

Fee-for-service claims incurred but not paid (IBNP)

$

1,346

$

1,562

Pharmacy payable

117

115

Capitation payable

63

52

Other (1)

241

232

$

1,767

$

1,961

______________________

(1)

“Other” medical claims and benefits payable include amounts payable to certain providers for which the Company acts as an intermediary on behalf of various state agencies without assuming financial risk. Such receipts and payments do not impact the Company’s consolidated statements of income. As of June 30, 2019 and December 31, 2018, the Company had recorded non-risk provider payables of approximately $112 million and $107 million, respectively.

CHANGE IN MEDICAL CLAIMS AND BENEFITS PAYABLE
(Dollars in millions)

The Company’s claims liability includes a provision for adverse claims deviation based on historical experience and other factors including, but not limited to, variations in claims payment patterns, changes in utilization and cost trends, known outbreaks of disease, and large claims. The Company’s reserving methodology is consistently applied across all periods presented. The amounts displayed for “Components of medical care costs related to: Prior period” represent the amount by which the original estimate of claims and benefits payable at the beginning of the period was more than the actual amount of the liability based on information (principally the payment of claims) developed since that liability was first reported. The following table presents the components of the change in medical claims and benefits payable for the periods indicated:

Six Months Ended

Year Ended

June 30,

Dec. 31,
2018

2019

2018

Medical claims and benefits payable, beginning balance

$

1,961

$

2,192

$

2,192

Components of medical care costs related to:

Current period

7,069

7,870

15,478

Prior period (1)

(232

)

(298

)

(341

)

Total medical care costs

6,837

7,572

15,137

Change in non-risk and other provider payables

4

56

13

Payments for medical care costs related to:

Current period

5,585

6,248

13,671

Prior period

1,450

1,652

1,710

Total paid

7,035

7,900

15,381

Medical claims and benefits payable, ending balance

$

1,767

$

1,920

$

1,961

Days in claims payable, fee for service (2)

48

49

53

(1)

The June 30, 2018, amount includes the 2018 benefit of the 2017 Marketplace CSR reimbursement of $76 million. December 31, 2018, includes the 2018 benefit of the 2017 Marketplace CSR reimbursement of $81 million.

(2)

Claims payable includes primarily IBNP. It also includes certain fee-for-service payables reported in “Other” medical claims and benefits payable amounting to $35 million, $33 million and $43 million, as of June 30, 2019, June 30, 2018, and December 31, 2018, respectively.

SUMMARY OF NON-RUN RATE ITEMS AFFECTING CURRENT QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS
(In millions, except per diluted share amounts)

The table below summarizes the impact of certain expenses and other items that management believes are not indicative of longer-term business trends and operations. The individual items presented below increase (decrease) income before income tax expense.

Three Months Ended June 30,

Six Months Ended June 30,

2019

2018

2019

2018

Amount

Per
Diluted
Share (1)

Amount

Per
Diluted
Share (1)

Amount

Per
Diluted
Share (1)

Amount

Per
Diluted
Share (1)

Restructuring costs

$

(2

)

$

(0.02

)

$

(8

)

$

(0.10

)

$

(5

)

$

(0.05

)

(33

)

(0.39

)

Gain (loss) on debt extinguishment

14

0.17

(5

)

(0.06

)

17

0.21

(15

)

(0.21

)

$

12

$

0.15

$

(13

)

$

(0.16

)

$

12

$

0.16

$

(48

)

$

(0.60

)

______________________

(1)

Except for permanent differences between GAAP and tax (such as certain expenses that are not deductible for tax purposes), per diluted share amounts are generally calculated at the statutory income tax rate of 22.6% and 22% for 2019 and 2018, respectively.

NON-GAAP FINANCIAL MEASURES

The Company uses non-generally accepted accounting principles, or non-GAAP, financial measures as supplemental metrics in evaluating the Company’s financial performance, making financing and business decisions, and forecasting and planning for future periods. For these reasons, management believes such measures are useful supplemental measures to investors in comparing the Company’s performance to the performance of other public companies in the health care industry. These non-GAAP financial measures should be considered as supplements to, and not as substitutes for or superior to, GAAP measures. See further information regarding non-GAAP measures below the tables.

Three Months Ended

Six Months Ended

June 30,

June 30,

2019

2018

2019

2018

Net income

$

196

$

202

$

394

$

309

Adjustments:

Depreciation, and amortization of intangible assets and capitalized software

22

33

47

67

Interest expense

22

32

45

65

Income tax expense

61

103

123

175

EBITDA

$

301

$

370

$

609

$

616

Adjustments made to GAAP measures used to calculate the non-GAAP measures used in this news release follow:

Earnings before interest, taxes, depreciation and amortization (“EBITDA”): Net income on a GAAP basis less depreciation, and amortization of intangible assets and capitalized software, interest expense and income tax expense. The Company believes that EBITDA is helpful in assessing the Company’s ability to meet the cash demands of its operating units.

NON-GAAP FINANCIAL MEASURES (CONTINUED)

Three Months Ended June 30,

Six Months Ended June 30,

2019

2018

2019

2018

Amount

Per
Diluted
Share

Amount

Per
Diluted
Share

Amount

Per
Diluted
Share

Amount

Per
Diluted
Share

Net income

$

196

$

3.06

$

202

$

3.02

$

394

$

6.04

$

309

$

4.68

Adjustment:

Amortization of intangible assets

4

0.07

5

0.08

9

0.14

10

0.16

Income tax effect (1)

(1

)

(0.02

)

(1

)

(0.02

)

(2

)

(0.03

)

(2

)

(0.04

)

Amortization of intangible assets, net of tax effect

3

0.05

4

0.06

7

0.11

8

0.12

Adjusted net income

$

199

$

3.11

$

206

$

3.08

$

401

$

6.15

$

317

$

4.80

________________________

(1)

Income tax effect of adjustments calculated at the blended federal and state statutory tax rate of 22.6% and 22% for 2019 and 2018, respectively.

Adjustments made to GAAP measures used to calculate the non-GAAP measures used in this news release follow:

Adjusted net income: Net income on a GAAP basis less amortization of intangible assets, net of income tax effect calculated at the statutory tax rate. The Company believes that adjusted net income is helpful in assessing the Company’s financial performance exclusive of the non-cash impact of the amortization of purchased intangibles.

Adjusted net income per diluted share: Adjusted net income divided by weighted average common shares outstanding on a fully diluted basis.

2019 REVISED GUIDANCE

Reconciliation of Non-GAAP Financial Measures

Low End

High End

(In millions)

Net income

$

725

$

740

Adjustments:

Depreciation, and amortization of intangible assets and capitalized software

90

90

Interest expense

90

90

Income tax expense

230

240

EBITDA

$

1,135

$

1,160

Investor Contact: Julie Trudell, [email protected], 562-912-6720

Media Contact: Laura Murray, [email protected], 562-506-9208

Source: Molina Healthcare, Inc.

Categories

Business Wire Press Releases

Next Articles